A safety and pharmacokinetic study of intravenous natalizumab in patients with MS

Conference proceeding

Peer reviewed

W. A Sheremata, T. L Vollmer, L. A Stone, A. J WILLMER-HULME and M Koller

Neurology, Vol.52(5), pp.1072-1074

1999

PMID: 10102433

Abstract

Biological and medical sciences

Immunomodulators

Medical sciences

Pharmacology. Drug treatments

12 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration
Citation topics: 1 Clinical & Life Sciences; 1.203 Neuromuscular Disorders; 1.203.147 Multiple Sclerosis
Web Of Science research areas: Clinical Neurology
ESI research areas: Neuroscience & Behavior

This output has contributed to the advancement of the following goals:

Source: InCites

Title: A safety and pharmacokinetic study of intravenous natalizumab in patients with MS
Creators: W. A Sheremata - University of Miami, FL, United States
T. L Vollmer - Yale University, New Haven, CT, United States
L. A Stone - Mayo Clinic, Scottsdale, AZ, United States
A. J WILLMER-HULME - Athena Neurosciences, Inc., South San Francisco, CA, United States
M Koller - Athena Neurosciences, Inc., South San Francisco, CA, United States
Publication Details: Neurology, Vol.52(5), pp.1072-1074
Publisher: Lippincott Williams & Wilkins
Language: English
Resource Type: Conference proceeding
PMID: 10102433
Record Identifier: 991031615211502976